Hodgkin Lymphoma — Trials

Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

972 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 179
Recruiting: 90
Ph III recruiting: 6
Growth YoY: −4.2%
Industry share: 11%
Top sponsor: City of Hope Medical Center
Termination share: 27.7%
Trials / 1,000 deaths: 175.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (145)

clinicaltrialsPublishedShowing 51–100 of 972 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07514819	Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma	recruiting	N/A	100	St. Jude Children's Research HospitalOTHER	1	Aug 21, 2026	clinicaltrials
NCT05922904	PET Adapted Brentuximab Vedotin and Pembrolizumab in Combination With Doxorubicin and Dacarbazine in Classic Hodgkin Lymphoma	active not recruiting	Phase 2	25	M.D. Anderson Cancer CenterOTHER	1	Aug 20, 2026	clinicaltrials